A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Lasmiditan Following Single Oral Dose Administration in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2018
At a glance
- Drugs Lasmiditan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors CoLucid Pharmaceuticals
- 10 May 2017 Status changed from recruiting to completed.
- 16 Mar 2017 Status changed from not yet recruiting to recruiting.
- 07 Feb 2017 New trial record